Beam Therapeutics Inc (BEAM) Event Aug. 09, 2022, 00:00 UTC (42% Neutral) Beam Therapeutics Inc. (BEAM) Reports Net Loss for 2022-06-30 Full text
Register to leave comments News bot Oct. 29, 2025, 6:47 p.m. 🏢 Beam Therapeutics Inc (BEAM) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-08-09 📊 Period of Report: 2022-06-30 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $-71.95M $-71.95M N/A +0.00% ➡️ Total Assets $1.47B $1.42B $56.08M +3.95% ↗️ Total Liabilities $647.72M $618.21M $29.50M +4.77% ↗️ Stockholders' Equity $800.16M $-909.44M $1.71B +187.98% 📈 Operating Income/Loss $-259.35M $-158.19M $-101.16M -63.95% 📈 R&D Expense $235.68M $139.97M $95.72M +68.39% 📉 Earningspersharebasic $-4.54 $-2.03 $-2.51 -123.65% 📉 Earningspersharediluted $-4.54 $-2.03 $-2.51 -123.65% 📉 📈 Financial Trend Analysis 🔻 Reported net loss for the period • ⚖️ Liability growth outpaced asset growth 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 Beam Therapeutics Inc (BEAM) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🔻 Reported net loss for the period • ⚖️ Liability growth outpaced asset growth
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document